99
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Neutrophil Gelatinase-Associated Lipocalin Contributes to Increased Risk of Cardiovascular Death After Acute Coronary Syndrome

ORCID Icon, , , , , & show all
Pages 4887-4895 | Published online: 27 Aug 2021

References

  • Darby SC, Ewertz M, Mcgale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–998. doi:10.1056/NEJMoa1209825
  • Kaplan H, Thompson RC, Trumble BC, et al. Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study. Lancet. 2017;389(10080):1730–1739. doi:10.1016/S0140-6736(17)30752-3
  • Yan R, Li W, Yin L, et al. Cardiovascular diseases and risk‐factor burden in urban and rural communities in high‐, middle‐, and low‐income regions of China: a large community‐based epidemiological study. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2017;6(2):e004445.
  • Zannad F, Anker SD, Byra WM, et al. Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease. N Engl J Med. 2018;379(14):1332–1342. doi:10.1056/NEJMoa1808848
  • Balsan G, Pellanda LC, Sausen G, et al. Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial. Nutr J. 2019;18(1):5. doi:10.1186/s12937-018-0426-y
  • Lin QY, Lang PP, Zhang YL, et al. Pharmacological blockage of ICAM-1 improves angiotensin II-induced cardiac remodeling by inhibiting adhesion of LFA-1+ monocytes. Am J Physiol Heart Circ Physiol. 2019;317(6):H1301–H1311. doi:10.1152/ajpheart.00566.2019
  • Kibel A, Lukinac AM, Dambic V, et al. Oxidative stress in ischemic heart disease. Oxid Med Cell Longev. 2020;2020(1):1–30. doi:10.1155/2020/6627144
  • Moran AE. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010. Circulation. 2014;129(14):1483–1492. doi:10.1161/CIRCULATIONAHA.113.004042
  • Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta. 2000;1482(1):272–283. doi:10.1016/S0167-4838(00)00152-7
  • Lippi G, Meschi T, Nouvenne A, et al. Neutrophil gelatinase-associated lipocalin in cancer. Adv Clin Chem. 2014;64:179–219.
  • Langelueddecke C, Roussa E, Fenton RA, et al. Lipocalin-2 (24p3/neutrophil gelatinase-associated lipocalin (NGAL)) receptor is expressed in distal nephron and mediates protein endocytosis. J Biol Chem. 2012;287(1):159–169. doi:10.1074/jbc.M111.308296
  • Han M, Li Y, Liu M, et al. Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat. BMC Nephrol. 2012;13:1.
  • Krizanac M, Mass Sanchez PB, Weiskirchen R, et al. A scoping review on Lipocalin-2 and Its role in non-alcoholic steatohepatitis and Hepatocellular carcinoma. Int J Mol Sci. 2021;22(6):2865. doi:10.3390/ijms22062865
  • Vandekerckhove L, Vermeulen Z, Liu ZZ, et al. Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk. Am J Physiol Endocrinol Metab. 2016;310(7):E495–504. doi:10.1152/ajpendo.00432.2015
  • Ferreira AC, Dá Mesquita S, Sousa JC, et al. From the periphery to the brain: lipocalin-2, a friend or foe? Prog Neurobiol. 2015;131:120–136. doi:10.1016/j.pneurobio.2015.06.005
  • Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394(10212):1949–1964. doi:10.1016/S0140-6736(19)32563-2
  • Maisel AS, Wettersten N, van Veldhuisen DJ, et al. Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study. J Am Coll Cardiol. 2016;68(13):1420–1431. doi:10.1016/j.jacc.2016.06.055
  • Mortara A, Bonadies M, Mazzetti S, et al. Neutrophil gelatinase-associated lipocalin predicts worsening of renal function in acute heart failure: methodological and clinical issues. J Cardiovasc Med. 2013;14:9. doi:10.2459/JCM.0b013e3283629ca6
  • Deursen VV, Damman K, Voors AA, et al. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure. Circ Heart Fail. 2013;7:1.
  • Jha MK, Jeon S, Jin M, et al. The pivotal role played by lipocalin-2 in chronic inflammatory pain. Exp Neurol. 2014;254:41–53. doi:10.1016/j.expneurol.2014.01.009
  • Czapski GA, Zhao Y, Lukiw WJ, et al. Acute systemic inflammatory response alters transcription profile of genes related to immune response and Ca2+ homeostasis in hippocampus; relevance to neurodegenerative disorders. Int J Mol Sci. 2020;21(21):7838. doi:10.3390/ijms21217838
  • van Deursen VM, Damman K, Voors AA, et al. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure. Circ Heart Fail. 2014;7(1):35–42. doi:10.1161/CIRCHEARTFAILURE.113.000242
  • Damman K, Veldhuisen DV, Navis G, et al. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail. 2014;10(10):997–1000. doi:10.1016/j.ejheart.2008.07.001
  • Gerych PR. Comorbid IHD in patients with COPD: definition, risk factors, diagnostic criteria. Galician Med J. 2014;21(4):38–42.
  • Demirel F, Rasoul S, Elvan A, et al. Impact of out-of-hospital cardiac arrest due to ventricular fibrillation in patients with ST-elevation myocardial infarction admitted for primary percutaneous coronary intervention: impact of ventricular fibrillation in STEMI patients. Eur Heart J Acute Cardiovasc Care. 2015;4(1):16–23. doi:10.1177/2048872614547448
  • Berardinis BD, Gaggin HK, Magrini L, et al. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure. Clin Chem Lab Med. 2015;53(4):613–621.
  • Vafadarnejad E, Rizzo G, Krampert L, et al. Dynamics of cardiac neutrophil diversity in murine myocardial infarction. Circ Res. 2020;127(9):e232–e249. doi:10.1161/CIRCRESAHA.120.317200
  • Lindberg S, Jensen JS, Mogelvang R, et al. Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis. Arterioscler Thromb Vasc Biol. 2014;34(9):2135–2142. doi:10.1161/ATVBAHA.114.303950
  • Daniels L, Barrett-Connor E, Clopton P, et al. Plasma neutrophil gelatinase–associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults. J Am College Cardiol. 2012;59(12):1101–1109. doi:10.1016/j.jacc.2011.11.046
  • Rozenfeld KL, Zahler D, Shtark M, et al. Elevated neutrophil gelatinase-associated lipocalin for the assessment of structural versus functional renal damage among ST-segment elevation myocardial infarction patients. Blood Purif. 2020;49(5):560–566. doi:10.1159/000506175
  • Yang B, Fan P, Xu A, et al. Improved functional recovery to I/R injury in hearts from lipocalin-2 deficiency mice: restoration of mitochondrial function and phospholipids remodeling. Am J Transl Res. 2012;4(1):60–71.
  • Aigner F, Maier HT, Schwelberger HG, et al. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am J Transplant. 2007;7(4):779–788. doi:10.1111/j.1600-6143.2006.01723.x
  • Schroll A, Eller K, Feistritzer C, et al. Lipocalin-2 ameliorates granulocyte functionality. Eur J Immunol. 2012;42(12):3346–3357. doi:10.1002/eji.201142351
  • Xu G, Ahn J, Chang S, et al. Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation. J Biol Chem. 2012;287(7):4808. doi:10.1074/jbc.M111.275719
  • Menees SB, Powell C, Kurlander J, et al. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol. 2015;110(3):444–54.